DISTINGUISHED ALUMNUS 2009
John B. Simpson, Ph.D. (1971), M.D.
Dr. Simpson is the founder of Sawtooth Labs, Inc. and Avinger Inc. Both companies are technology development companies where products will be developed primarily for the medical field and include software, hardware, and interventional cardiovascular medical devices. Prior to Sawtooth Labs and Avinger, Dr. Simpson is the founder of Perclose (now, an Abbott Laboratories company) and Lumend, Inc. (currently, a Johnson & Johnson Company).
In addition, he is the founder of FoxHollow Technologies (recently merged with ev3, Inc.) and serves as Vice Chairman of the Board and Chief Scientist with ev3, Inc. He also serves as Professor of Clinical Medicine at Stanford University and a Staff Cardiologist at Sequoia Hospital (Redwood City, California). He completed his undergraduate education at Ohio State University and received his Masters and Doctorate degrees in Biomedical Science at the University of Texas. He is a graduate of the Duke University Medical School and completed his fellowship in interventional cardiology at Stanford University. He is a fellow of the American College of Cardiology and a member of the American College of Physicians.
Dr. Simpson has been honored with the Andreas Greuntzig Award from the European Cardiology Society, Duke Alumni Award from Duke University School of Medicine, and Lifetime Achievement Awards from the Transcatheter Cardiovascular Therapeutics and Cardiovascular Institute of the South.
He has published extensively on a wide variety of topics on interventional cardiology and has lectured on various subjects throughout the world.
Congratulations to Dr. Simpson on his award as The University of Texas Graduate School of Biomedical Sciences at Houston Distinguished Alumnus, 2009-2010.